Abstract
Background
Behçet’s disease (BD) is a systemic multi-system vasculitis that can have a wide range of effects on the cardiovascular system.
Objective
To determine the existence of myocardial perfusion defects caused by coronary microvascular dysfunction in BD and to evaluate coronary arterial distribution and left ventricular systolic function by gated single-photon emission computed tomography (SPECT).
Methods
The study population consisted of 23 (15 men and 8 women) patients with BD and 20 healthy controls (12 men and 8 women). Technetium-99m methoxyisobutylisonitrile (Tc-99m MIBI) gated SPECT studies were performed at stress and rest in a 2-day protocol. Stress and rest left ventricular ejection fraction (LVEF) were calculated. Using non-gated SPECT images myocardial perfusion scores [summed stress score (SSS), summed rest score (SRS), summed difference score (SDS), and fix defect score (FDS)] and perfusion defect extent as percentage (stress, rest ischemic, and fix %LV) were determined. Using gated SPECT images, wall motion score indices (stress wall motion score indices and rest wall motion score indices) were calculated. Coronary angiography (CAG) was applied to patients with abnormal myocardial perfusion scintigraphy (MPS).
Results
The mean ages of the BD and control groups were 39.3 ± 10.6 years and 36.2 ± 8.3 years, respectively. No statistically significant differences were observed between the two groups regarding clinical features and cardiologic findings. Abnormal MPS was found in 13 (56.5%) of the BD patients; 3 patients had non-transmural infarcts and 10 patients reversible perfusion defects. Reversible perfusion defects were also found in two controls (10.0%). When the two groups were compared regarding the gated SPECT findings, differences were determined in the following parameters; SSS, SRS, SDS, FDS, stress and rest LVEF, stress and rest %LV, and stress and rest WMSI. In the BD group, when gated SPECT results were compared between those with and without abnormal MPS, differences were determined in SSS, SRS, SDS, FDS, stress and rest %LV, and stress and rest WMSI. Epicardial coronary arteries were normal in CAG.
Conclusions
Myocardial perfusion and function are disturbed owing to influenced coronary microvascularity in BD, and CAG is frequently observed to be normal. Gated SPECT is a non-invasive reliable method that simultaneously evaluates the existence, extent and severity of myocardial ischemia or infarction and the wall movements in cardio-Behçet.
Similar content being viewed by others
References
Marshall SE. Behçet’s disease. Best Pract Res Clin Rheumatol 2004;18:291–311.
International Study Group for Behçet’s Disease. Criteria for diagnosis of Behçet’s disease. Lancet 1990;335:1078–1080.
Yazıcı H, Yurdakul S, Hamuryudan V. Behçet’s syndrome. In: Klippel JH, Dieppe PA, editors. Rheumatology. vol. 2. London: Mosby; 1998. p. 1–6.
Baykan M, Celik S, Erdöl C, Baykan EC, Durmus I, Bahadir S, et al. Behçet’s disease with a large intracardiac thrombus: a case report. Heart 2001;85:e7.
Gullu IH, Benekli M, Muderrisoglu H, Oto A, Kansu E, Kabakcı G, et al. Silent myocardial ischemia in Behçet’s disease. J Rheumatol 1996;23:323–327.
Chajek T, Fainaru M. Behçet’s disease: report of 41 cases and a review of the literature. Medicine 1975;54:179–196.
Gemici K, Baran I, Gullulu S, Kazazoglu AR, Cordan J, Ozer Z. Evaluation of diastolic dysfunction and repolarization dispersion in Behcet’s disease. Int J Cardiol 2000;73:143–148.
Lie JT. Vascular involvement in Behçet’s disease: arterial and venous and vessels of all sizes. J Rheumatol 1992;19:341–343.
James DG, Thomson A. Recognition of the diverse cardiovascular manifestations in Behçet’s disease. Am Heart J 1982;103:457–458.
O’Duffy JD. Vasculitis in Behçet’s disease. Rheumatol Dis Clin North Am 1990;16:423–431.
Koç Y, Gullu I, Akpek G, Akpolat T, Kansu E, Kiraz S, et al. Vascular involvement in Behçet’s disease. J Rheumatol 1992;19:402–410.
Gurgun C, Ercan E, Ceyhan C, Yavuzgil O, Zoghi M, Aksu K, et al. Cardiovascular Involvement in Behçet’s disease. Jpn Heart J 2002;43:389–398.
Turkolmez S, Gokcora N, Alkan M, Gürer MA. Evaluation of myocardial perfusion in patients with Behçet’s disease. Ann Nucl Med 2005;19:201–206.
Akar H, Konuralp C, Akpolat T. Cardiovascular involvement in Behçet’s disease. Anadolu Kardiyol Derg 2003;3:261–265.
Sciagra R, Leoncini M. Gated single-photon emission computed tomography: the present-day “one-stop-shop” for cardiac imaging. Q J Nucl Med Mol Imaging 2005;49:19–29.
Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, et al. A reporting system on patients evaluated for coronary artery disease, report of the ad hoc committee for grading of coronary artery disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975;51:7–34.
Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the Heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539–542.
Jamil G, Ahlberg AW, Elliott MD, Hendel RC, Holly T, McGill CC, et al. Impact of limited treadmill exercise on adenosine Tc-99m sestamibi single photon emission computed tomographic myocardial perfusion imaging in coronary artery disease. Am J Cardiol 1999;84:400–403.
Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death. Circulation 1998;97:535–543.
Levine MG, Ahlberg AW, Mann A, White MP, McGill CC, Mendes de Leon C, et al. Comparison of exercise, dipyridamole, adenosine, and dobutamine stress with the use of Tc-99m tetrofosmin tomographic imaging. J Nucl Cardiol 1999;6:389–396.
Abidov A, Germano G, Hachamovitch R, Berman DS. Gated SPECT in assessment of regional and global left ventricular function: major tool of modern nuclear imaging. J Nucl Cardiol 2006;13:261–279.
Chua T, Kiat H, Germano G, Maurer G, van Train K, Friedman J, et al. Gated technetium-99m sestamibi for simultaneous assessment of stress myocardial perfusion, postexercise regional ventricular function and myocardial viability: correlation with echocardiography and rest thallium-201 scintigraphy. J Am Coll Cardiol 1994;23:1107–1114.
Sakane T, Takeno M, Suzuki N, Inaba G. Behçet’s disease. N Engl J Med 1999;341:1284–1291.
Sismanoglu M, Omeroglu SN, Mansuroglu D, Ardal H, Erentug V, Kaya E, et al. Coronary artery disease and coronary artery bypass grafting in Behçet’s disease. J Card Surg 2005;20:160–163.
Huong DL, Wechsler B, Papo T, de Zuttere D, Bletry O, Hernigou A, et al. Endomyocardial fibrosis in Behçet’s disease. Ann Rheum Dis 1997;56:205–208.
Shmitz-Haubner U, Knop J. Evidence for endothelial cell dysfunction in association with Behçet’s disease. Thromb Res 1984;34:277–285.
Gimbrone MA Jr. Vascular endothelium: an integrator of pathophysiologic stimuli in atherosclerosis. Am J Cardiol 1995;75:67B–70B.
Chambers JC, Haskard DO, Kooner JS. Vascular endothelial function and oxidative stress mechanisms in patients with Behçet’s syndrome. J Am Coll Cardiol 2001;37:517–520.
Daou D, Delahaye N, Vilain D, Lebtahi R, Faraggi M, Le Guludec D. Identification of extensive coronary artery disease: incremental value of exercise Tl-201 SPECT to clinical and stress test variables. J Nucl Cardiol 2002;9:161–168.
Nallamothu N, Ghods M, Heo J, Iskandrian AS. Comparison of thallium-201 single-photon emission computed tomography and electrocardiographic response during exercise in patients with normal rest electrocardiographic results. J Am Coll Cardiol 1995;25:830–836.
Kosar F, Sahin I, Gullu H, Cehreli S. Acute myocardial infarction with normal coronary arteries in a young man with the Behçet’s disease. Int J Cardiol 2005;99:355–357.
Gullu H, Caliskan M, Erdogan D, Yilmaz S, Dursun R, Ciftci O, et al. Impaired coronary microvascular functions in patients with Behçet disease. J Am Coll Cardiol 2006;48:586–587.
Melua A, Campbell N, McCluskey D, MacGowan SW. Aorto-atrial fistula without aneurysm formation in Behçet’s disease. Heart 1998;80:200–201.
Ozeren M, Dogan OV, Dogan S, Yucel E. True and pseudo aneurysms of coronary arteries in a patient with Behçet’s disease. Eur J Cardiothorac Surg 2004;25:465–467.
Karata K, Onder M, Meray J. Autonomic nervous system involvement in Behçet’s disease. Rheumatol Int 2002;22:155–159.
Hattori S, Kawana S. Behçet’s syndrome associated with acute myocardial infarction. J Nippon Med Sch 2003;70:49–52.
Iyisoy A, Kursaklioglu H, Kose S, Yesilova Z, Ozturk C, Saglam K, et al. Acute myocardial infarction and left subclavian artery occlusion in Behçet’s disease. Mt Sinai J Med 2004;71:330–334.
Yazici H, Fresko I, Yurdakul S. Behçet’s syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol 2007;3:148–155.
Go V, Bhatt MR, Hendel RC. The diagnostic and prognostic value of ECG-gated SPECT myocardial perfusion imaging. J Nucl Med 2004;45:912–921.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kaya, E., Saglam, H., Ciftci, İ. et al. Evaluation of myocardial perfusion and function by gated SPECT in patients with Behçet’s disease. Ann Nucl Med 22, 287–295 (2008). https://doi.org/10.1007/s12149-007-0115-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12149-007-0115-y